Idelalisib ‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme
Source: British Journal of Haematology - Category: Hematology Authors: Toby A. Eyre, Christopher P. Fox, Ali Boden, Adrian Bloor, Moez Dungawalla, Paneesha Shankara, Richard Went, Anna H. Schuh Tags: Correspondence Source Type: research